Good Manufacturing Practice‐Grade of Megakaryocytes Produced by a Novel Ex Vivo Culturing Platform

Ex vivo (EV)‐derived megakaryocytes (MKs) have shown great promise as a substitute for platelets in transfusion medicine to alleviate a severe shortage of donor‐platelets. Challenges remain that include poor efficiency, a limited scale of production, and undefined short‐term storage conditions of EV...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Xin, Wang, Lan, Wang, Hanlu, Wang, Huihui, Dai, Wei, Jiang, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719378/
https://www.ncbi.nlm.nih.gov/pubmed/33030809
http://dx.doi.org/10.1111/cts.12788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719378/
https://www.ncbi.nlm.nih.gov/pubmed/33030809
http://dx.doi.org/10.1111/cts.12788

Ejemplares similares